Inhaled nitric oxide (INO) therapy 3,500 HRS.
Ended Awarded Last action
- Contract number
- N0025921F0021
- Awardee
-
INO Therapeutics LLC UEI XXQHL619FUN6
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $602,910
Award facts
- Contract value 100% obligated
- $602,910.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6830 Gases: Compressed And Liquefied
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Hampton, NJ 08827, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $136,185 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $173,530 | |
| Original award | $293,195 |
About this award
The Defense Health Agency awarded a delivery order valued at $602,910 to INO Therapeutics LLC for 3,500 hours of inhaled nitric oxide (INO) therapy services, with an ultimate completion date of January 9, 2024. This firm fixed-price delivery order, issued under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB), represents a modification to an existing option year contract and does not utilize a set-aside designation. The work will be performed in Hampton, New Jersey, supporting the Defense Health Agency's medical gas supply and respiratory therapy requirements for military beneficiaries and service members.
INO Therapeutics LLC, a Missouri-based supplier of specialized medical gases and respiratory therapy systems, is well-established in providing inhaled nitric oxide solutions to federal healthcare agencies. The company has been active in the federal contracting market since 2002 and holds multiple blanket purchase agreements with both the Defense Health Agency and the Department of Veterans Affairs for similar medical gas delivery services. This delivery order reflects the company's ongoing role as a critical supplier of inhaled nitric oxide therapeutic gas, which is utilized for neonatal, pediatric, and critical care treatments across federal medical facilities.
Quick answers
Who was awarded contract N0025921F0021?
N0025921F0021 was awarded to INO Therapeutics LLC by Bureau of Medicine and Surgery (Department of the Navy) on January 8, 2021.
How much is contract N0025921F0021 worth?
The government has obligated $602,910 on N0025921F0021.
Which agency awarded contract N0025921F0021?
Bureau of Medicine and Surgery (Department of the Navy) awarded N0025921F0021, with funding from Defense Health Agency (Department of Defense).
Is contract N0025921F0021 an order under another contract?
Yes. N0025921F0021 is a delivery order under V797D60737, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract N0025921F0021 competed?
The extent of competition for N0025921F0021 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award